Qiu, T., Chen, W., Li, P., Sun, J., Gu, Y., & Chen, X. (2018). Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer. Onco Targets Ther.

Qiu, Tianzhu, Wensen Chen, Ping Li, Jing Sun, Yanhong Gu, a Xiaofeng Chen. "Subsequent Anti-VEGF Therapy After First-line Anti-EGFR Therapy Improved Overall Survival of Patients With Metastatic Colorectal Cancer." Onco Targets Ther 2018.

Qiu, Tianzhu, et al. "Subsequent Anti-VEGF Therapy After First-line Anti-EGFR Therapy Improved Overall Survival of Patients With Metastatic Colorectal Cancer." Onco Targets Ther 2018.